IMHO, the last three press releases have been good news for investors who already know about Titan. By completing the feasibility prototype, signing a manufacturing agreement for surgical tools, and signing an agreement with a training center, Titan has given us a lot of reason to believe that they are back on track after the November delay.
For the rest of the market, however, I think the catalysts that will get the share price moving will have to be much more substantial to wake up the institutional investors. Here are some examples of what I think would be enough to kick the share price up:
1. Announcement that clinical trials are about to begin at the test sites
2. Live demonstration of the SPORT system in some kind of public forum
3. Partnering up with a major medical device company
4. Uplisting of the stock on the US side to one of the major exchanges.
5. Mainstream media picking up on the "wow" factor of a flexible robot that can do surgery through a hole the size of a quarter and running a piece on that
I haven't sold any of my position 2 1/2 years and added significantly to it last year because I strongly believe that these guys are going to succeed and that one of the five things above will happen at some point in the near future. Like many of you, I was rattled by the November delay, but at the time I tried to focus on the promise of them going for multiple indications instead of just choles. So far, that blind faith seems to have paid off. Let's see where the story goes from here.
News 
Market Data 
Discover 
